Cash from Discontinued Operations Adjustment (Quarterly) Chart

View Cash from Discontinued Operations Adjustment (Quarterly) for GPCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Discontinued Operations Adjustment (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Novo Nordisk A/S --
Pfizer Inc. --
Viking Therapeutics, Inc. --
Dyne Therapeutics, Inc. --